Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6501
    +0.0001 (+0.02%)
     

  • OIL

    82.79
    -0.02 (-0.02%)
     

  • GOLD

    2,328.20
    -10.20 (-0.44%)
     

  • Bitcoin AUD

    98,796.40
    -3,472.54 (-3.40%)
     

  • CMC Crypto 200

    1,388.21
    -35.89 (-2.52%)
     

  • AUD/EUR

    0.6072
    +0.0002 (+0.03%)
     

  • AUD/NZD

    1.0945
    +0.0003 (+0.03%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

Norway should exclude J&J, AstraZeneca from COVID vaccination scheme, says commission

Reuters
Updated ·1-min read

OSLO, May 10 (Reuters) - Norway should exclude the COVID-19 vaccines made by AstraZeneca and Johnson & Johnson in its inoculation program due to a risk of rare but harmful side-effects, a government-appointed commission said on Monday.

Those who would volunteer to take either of the two vaccines should however be allowed to do so, the commission added.

Authorities on March 11 suspended the AstraZeneca rollout after a small number of younger inoculated people were hospitalised for a combination of blood clots, bleeding and a low count of platelets, some of whom later died.

On April 15, the Norwegian Institute of Public Health said the AstraZeneca vaccine should be dropped entirely but the government instead sought further advice, including on the jabs made by J&J which the country has yet to adopt. (Reporting by Terje Solsvik, editing by Gwladys Fouche)